GALVUPLUS, created in 2007 (Switzerland), from 2951 sister brands and 17478 competing brands. GALVUPLUS is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. GALVUPLUS is part of the Drug Manufacturers activity sector.